128 related articles for article (PubMed ID: 34417926)
21. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
[TBL] [Abstract][Full Text] [Related]
22. Association between obesity categories with cardiovascular disease and its related risk factors in the MASHAD cohort study population.
Ghazizadeh H; Mirinezhad SMR; Asadi Z; Parizadeh SM; Zare-Feyzabadi R; Shabani N; Eidi M; Mosa Farkhany E; Esmaily H; Mahmoudi AA; Mouhebati M; Oladi MR; Rohban M; Sharifan P; Yadegari M; Saeidi F; Ferns GA; Ghayour-Mobarhan M
J Clin Lab Anal; 2020 May; 34(5):e23160. PubMed ID: 31837061
[TBL] [Abstract][Full Text] [Related]
23. Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies.
Koohi F; Khalili D; Mansournia MA; Hadaegh F; Soori H
J Transl Med; 2021 Jul; 19(1):286. PubMed ID: 34217318
[TBL] [Abstract][Full Text] [Related]
24. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.
Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929
[TBL] [Abstract][Full Text] [Related]
26. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus.
Liu S; Ke J; Feng X; Wang Z; Wang X; Yang L; Zhao D
J Diabetes Res; 2024; 2024():2431441. PubMed ID: 38577301
[TBL] [Abstract][Full Text] [Related]
28. The association between a Fatty Acid Binding Protein 1 (FABP1) gene polymorphism and serum lipid abnormalities in the MASHAD cohort study.
Valizadeh M; Aghasizadeh M; Nemati M; Hashemi M; Aghaee-Bakhtiari SH; Zare-Feyzabadi R; Esmaily H; Ghazizdaeh H; Sahebi R; Ahangari N; Ferns GA; Pasdar A; Ghayour-Mobarhan M
Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102324. PubMed ID: 34418801
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State.
Tikkanen E; Minicocci I; Hällfors J; Di Costanzo A; D'Erasmo L; Poggiogalle E; Donini LM; Würtz P; Jauhiainen M; Olkkonen VM; Arca M
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):665-674. PubMed ID: 30816800
[TBL] [Abstract][Full Text] [Related]
30. Association of Genotypes of ANGPTL3 with Vitamin D and Calcium Concentration in Cardiovascular Disease.
Aghasizadeh M; Ghanei M; Ghoflchi S; Asadian-Sohan P; Haghani M; Kazemi T; Esmaily H; Avan A; Ferns GA; Miri-Moghaddam E; Ghayour-Mobarhan M
Biochem Genet; 2023 Nov; ():. PubMed ID: 37955843
[TBL] [Abstract][Full Text] [Related]
31. Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3.
Oldoni F; Palmen J; Giambartolomei C; Howard P; Drenos F; Plagnol V; Humphries SE; Talmud PJ; Smith AJ
Atherosclerosis; 2016 Mar; 246():193-201. PubMed ID: 26800306
[TBL] [Abstract][Full Text] [Related]
32. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
33. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
Cai HJ; Li ZX; Yang SM
Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
[TBL] [Abstract][Full Text] [Related]
34. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
[TBL] [Abstract][Full Text] [Related]
35. A Genetic Variant in Proline and Serine Rich Coiled-Coil 1 Gene Is Associated with the Risk of Cardiovascular Disease.
Khorrami MS; Sadabadi F; Pasdar A; Safarian-Bana H; Amerizadeh F; Esmaeily H; Moohebati M; Heidari-Bakavoli A; Ferns G; Ghayour-Mobarhan M; Avan A
Rep Biochem Mol Biol; 2022 Jan; 10(4):653-663. PubMed ID: 35291603
[TBL] [Abstract][Full Text] [Related]
36. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
[TBL] [Abstract][Full Text] [Related]
37. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke.
Li WJ; Yin RX; Cao XL; Chen WX; Huang F; Wu JZ
Lipids Health Dis; 2018 Feb; 17(1):30. PubMed ID: 29454388
[TBL] [Abstract][Full Text] [Related]
38. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
39. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
40. Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice.
Bell TA; Liu M; Donner AJ; Lee RG; Mullick AE; Crooke RM
J Lipid Res; 2021; 62():100101. PubMed ID: 34371033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
